drugset / Trial / NCT00450086

Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis

NCT00450086

Phase 3 Completed 92 enrolled Dr. Falk Pharma GmbH
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether budesonide or mesalazine is more active in the treatment of collagenous colitis.

Timeline

Start
2007-03
Primary completion
2011-06
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Budesonide Small molecule 9 mg Oral
Subject Mesalamine Small molecule 3 g

Indications